Pharma News

The Indian Academy of Paediatrics (IAP) in partnership with HealthPhone, Ministry of Women and Child Development (MWCD), Government of India and UNICEF, announced launch of the IAP HealthPhone programme, the world's largest digital mass education programme to face the challenge of malnutrition in women and children, at the national-level in India. The programme will achieve its objectives by widely promoting and distributing four re-edited videos from the Poshan series, jointly produced by MWCD and UNICEF in 18 Indian languages. The Poshan videos address issues of status of women, the care of pregnant women and children under two, breastfeeding and the importance of balanced diet, health and simple changes in nutritional care practices that can notably enhance nutrition levels.

Amgen join with Roche on a phase 1b study to evaluate the safety and efficacy of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with Roche's investigational anti-PDL1 therapy, atezolizumab (also known as MPDL3280A), in patients with triple-negative breast cancer and colorectal cancer with liver metastases.

Researchers has found the mechanism whereby cancerous cells manage to spread from their original location to other parts of the body through the process known as metastasis.. A new study has found the mechanism of metastasis. Researchers compared the genetic material in the primary tumor's cells with the genetic material from metastasized cells in the same patient. They found that among all patient's genes, there is just one that clearly differs between those two groups. That gene, known as TBC1D16, in the initial tumor is inactive or dormant, while in the metastasized phase it is still active.

[adsense:336x280:8701650588]

The growth of the Indian metallic packaging industry is highly dependent on the progress made by the overall economy. With the country’s economy doing fairly well, the retail sector booming, and consumer awareness on the recycling and environmental benefits of tinplate packaging rising, the outlook for the industry looks positive.

Glenmark Pharmaceuticals granted tentative approval by the US health regulator to sell Rufinamide, which is used to treat seizures caused by Lennox-Gastaut syndrome.

DeNovo Sciences, Inc., an innovator of cutting edge products of liquid biopsy, sign an agreement with START (South Texas Accelerated Research Therapeutics), a San Antonio based phase I medical oncology programme, one of the world’s largest of its kind with clinical trial sites on three continents.  As per agreement, START will collect blood samples of  cancer patients and use DeNovo instruments and reagents for circulating tumour cells (CTC) enrichment and purification. This will further will then be sent to a large genomics lab for whole genome sequencing. In addition, START and DeNovo have signed a separate agreement to test the ability of Denovo CTC platform to capture CTCs for use in patient derived xenograft (PDX) mice models for drug discovery and biomarker development purposes.